For last 15 years, breast cancer has been classified based on the expression of certain hormone receptors, namely progesterone receptor (PR), estrogen receptor (ER) and anti–human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and breast carcinoma.